JPMorgan Multi-Asset Growth & Income Share Forecast, Price & News

Wall Street analysts have given JPMorgan Multi-Asset Growth & Income a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but JPMorgan Multi-Asset Growth & Income wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

JPMorgan Multi-Asset Growth & Income is scheduled to release its next quarterly earnings announcement on Monday, June 21st 2021.
View our earnings forecast for JPMorgan Multi-Asset Growth & Income.

JPMorgan Multi-Asset Growth & Income's stock was trading at GBX 96.60 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MATE shares have increased by 5.6% and is now trading at GBX 102.
View which stocks have been most impacted by COVID-19.

JPMorgan Multi-Asset Growth & Income announced a dividend on Thursday, March 25th. Shareholders of record on Thursday, April 1st will be paid a dividend of GBX 1 per share on Thursday, May 6th. This represents a dividend yield of 1.03%. The ex-dividend date of this dividend is Thursday, April 1st. The official announcement can be accessed at this link.
View JPMorgan Multi-Asset Growth & Income's dividend history.

JPMorgan Multi-Asset Growth & Income pays an annual dividend of GBX 4 per share and currently has a dividend yield of 3.86%.
View JPMorgan Multi-Asset Growth & Income's dividend history.

Some companies that are related to JPMorgan Multi-Asset Growth & Income include Witan Pacific Investment Trust PLC (WPC.L) (WPC), Honeycomb Investment Trust (HONY), Aberdeen Emerging Markets Investment (AEMC), Martin Currie Global Portfolio Trust (MNP), Woodford Patient Capital Trust (WPCT), Real Estate Credit Investments (RECI), Henderson International Income Trust (HINT), JPMorgan Mid Cap Investment Trust (JMF), Unicorn AIM VCT (UAV), Polar Capital Global Healthcare Trust (PCGH), The Independent Investment Trust (IIT), Montanaro European Smaller Companies Trust (MTE), JPMorgan Russian Securities (JRS), JPMorgan Japan Small Cap Growth & Income plc (JPS.L) (JPS) and Gresham House (GHE).
View all of MATE's competitors.

JPMorgan Multi-Asset Growth & Income trades on the London Stock Exchange (LON) under the ticker symbol "MATE."

Shares of MATE and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of MATE stock can currently be purchased for approximately GBX 102.

JPMorgan Multi-Asset Growth & Income has a market capitalization of £85.09 million.

The official website for JPMorgan Multi-Asset Growth & Income is am.jpmorgan.com.